Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 2/20 | 0.47 |
| ▸ | FEN1 | P39748 | 2/20 | 0.47 |
| ▸ | AR | P10275 | 14/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 2/20 | 0.40 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.37 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25658487 | 0.88 | FEN1 (0.57) | ALOX5APFEN1ARCYP11B1CYP11B2 | |
| SCHEMBL25658409 | 0.86 | KIF11 (0.50) | ALOX5APFEN1ARCYP11B1CYP11B2 | |
| SCHEMBL20111587 | 0.84 | ALOX5AP (0.47) | ALOX5APFEN1ARCYP11B1CYP11B2 | |
| SCHEMBL20616789 | 0.82 | AR (0.61) | ALOX5APFEN1ARCYP11B1CYP11B2 | |
| SCHEMBL20111535 | 0.78 | AR (0.46) | ALOX5APFEN1ARCYP11B1CYP11B2 | |
| SCHEMBL19903462 | 0.77 | CYP11B1 (0.48) | ALOX5APFEN1ARCYP11B1CYP11B2 | |
| SCHEMBL20111586 | 0.77 | AR (0.45) | ALOX5APFEN1ARCYP11B1CYP11B2 | |
| SCHEMBL21898833 | 0.75 | AR (0.46) | ARCYP11B1CYP11B2KIF11PGR | |
| SCHEMBL25658426 | 0.75 | ALOX5AP (0.55) | ALOX5APFEN1ARCYP11B1CYP11B2 | |
| SCHEMBL1360894 | 0.74 | KIF11 (0.62) | ALOX5APFEN1ARCYP11B2KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10971688-B2 | Organic molecules for use in organic optoelectronic devices | CYNORA GMBH (DE) | 2021-04-06 | — | — | US | disclosed |
| US-20190248741-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-08-15 | — | — | US | disclosed |
| EP-3360945-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | CYNORA GMBH (DE) | 2019-04-24 | — | — | EP | disclosed |
| WO-2018077492-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10971688-B2 | Organic molecules for use in organic optoelectronic devices | OR10J3, OR51E2, OPRM1 | ALOX5AP 2592/4885FEN1 1121/4885AR 4611/4885 |
| US-20190248741-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, AOC3 | ALOX5AP 3253/4885FEN1 1286/4885AR 4386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.